Randall Eck News Today

In November, researchers reported the drug lecanemab slowed the progression of Alzheimer's disease. The effect was modest, but it has generated tremendous excitement because it was the first time a drug had been shown to be able to affect the course of this relentless, incurable disease.

The program is being led by Dr. Daniela Zarnescu, a Molecular and Cellular Biology faculty member and experienced Beckman Mentor. Faculty mentors are drawn from three UArizona departments within the College of Science: Chemistry and Biochemistry, Ecology and Evolutionary Biology, and Molecular and Cellular Biology.